Abstract
Vascularized composite allotransplantation (VCA) has become an important modality to restore disfigured parts of the body that cannot be restored with conventional reconstructive techniques. Reported short- and long-term functional and esthetic outcomes have been excellent. However, acute rejection remains the most common complication associated with VCA. In addition, recent reports have linked the loss of some allografts to chronic rejections potentially fueled by insufficiently treated acute rejections. Here, we highlight recent diagnostic and therapeutic strategies for the prevention and treatment of acute and chronic rejections in VCA.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
